T1	chemical 3 13	furosemide
T2	chemical 62 66	drug
T3	disease_or_phenotypic_feature 154 167	renal failure
T4	disease_or_phenotypic_feature 178 193	cardiac failure
T5	disease_or_phenotypic_feature 249 255	cancer
T6	chemical 256 260	drug
T7	disease_or_phenotypic_feature 271 282	Hypokalemia
T8	disease_or_phenotypic_feature 284 297	hyperuricemia
T9	chemical 309 320	Triamterene
T10	chemical 348 357	rapamycin
T11	chemical 381 395	mTOR inhibitor
T12	disease_or_phenotypic_feature 430 435	HNSCC
T13	chemical 466 473	biology
T14	disease_or_phenotypic_feature 477 484	obesity
T15	disease_or_phenotypic_feature 517 537	cognitive impairment
T16	disease_or_phenotypic_feature 539 558	psychiatric disease
T17	chemical 560 564	drug
T18	chemical 575 582	alcohol
T19	chemical 624 629	Tc-99
T20	chemical 631 640	sestamibi
T21	disease_or_phenotypic_feature 682 709	primary hyperparathyroidism
T22	disease_or_phenotypic_feature 753 772	hyperparathyroidism
T23	disease_or_phenotypic_feature 817 823	glioma
T24	chemical 835 856	5-aminolevulinic acid
T25	chemical 858 863	5-ALA
T26	chemical 869 880	fluorescein
T27	chemical 881 887	sodium
T28	chemical 998 1006	antigens
T29	disease_or_phenotypic_feature 1010 1018	melanoma
T30	chemical 1061 1075	growth hormone
T31	disease_or_phenotypic_feature 1091 1103	hypogonadism
T32	chemical 1104 1117	Valproic acid
T33	disease_or_phenotypic_feature 1132 1138	cancer
T34	chemical 1139 1143	drug
T35	chemical 1227 1230	PCG
T36	disease_or_phenotypic_feature 1234 1241	obesity
T37	disease_or_phenotypic_feature 1246 1253	obesity
T38	chemical 1275 1282	oxidant
T39	chemical 1339 1353	Growth hormone
T40	disease_or_phenotypic_feature 1370 1386	islet cell tumor
T41	disease_or_phenotypic_feature 1387 1399	hypoglycemia
T42	chemical 1441 1447	oxygen
T43	disease_or_phenotypic_feature 1498 1516	prostate carcinoma
T44	chemical 1529 1532	Ras
T45	chemical 1565 1568	Ras
T46	chemical 1581 1589	estrogen
T47	chemical 1607 1616	inhibitor
T48	disease_or_phenotypic_feature 1655 1668	breast cancer
T49	chemical 1764 1767	Ras
T50	chemical 1781 1798	Megestrol acetate
T51	chemical 1857 1864	hormone
T52	disease_or_phenotypic_feature 1865 1874	sensitive
T53	chemical 1967 1974	hormone
T54	disease_or_phenotypic_feature 2009 2016	obesity
T55	chemical 2028 2032	drug
T56	chemical 2048 2052	drug
T57	disease_or_phenotypic_feature 2061 2081	tumor lysis syndrome
T58	disease_or_phenotypic_feature 2101 2118	hyperphosphatemia
T59	disease_or_phenotypic_feature 2120 2132	hyperkalemia
T60	disease_or_phenotypic_feature 2137 2149	hypocalcemia
T61	chemical 2190 2199	rapamycin
T62	chemical 2200 2210	inhibitors
T63	disease_or_phenotypic_feature 2248 2274	hematological malignancies
T64	chemical 2327 2341	growth hormone
T65	disease_or_phenotypic_feature 2376 2396	valvular abnormality
T66	disease_or_phenotypic_feature 2401 2411	arrhythmia
T67	corrected_disease_or_phenotypic_feature 430 440	HNSCC-tumo
R1	treats Arg1:T10 Arg2:T67	
R2	treats Arg1:T11 Arg2:T67	
R3	treats Arg1:T32 Arg2:T33	
T68	corrected_disease_or_phenotypic_feature 1366 1399	non-islet cell tumor hypoglycemia
R4	treats Arg1:T39 Arg2:T68	
T69	corrected_chemical 1529 1563	Ras GTPase superfamily member RERG
R5	treats Arg1:T69 Arg2:T48	
T70	corrected_chemical 1565 1616	Ras-related and estrogen-regulated growth inhibitor
R6	treats Arg1:T70 Arg2:T48	
T71	corrected_chemical 2190 2210	rapamycin inhibitors
T72	missed_disease_or_phenotypic_feature 2231 2243	solid tumors
R8	treats Arg1:T71 Arg2:T72	
R9	treats Arg1:T71 Arg2:T63	
T73	missed_disease_or_phenotypic_feature 1198 1210	solid tumors
R10	treats Arg1:T32 Arg2:T73	
T74	corrected_chemical 1121 1143	epigenetic cancer drug
R11	treats Arg1:T74 Arg2:T73	
T75	corrected_chemical 1559 1563	RERG
R12	treats Arg1:T75 Arg2:T48	
T76	missed_disease_or_phenotypic_feature 1828 1839	weight gain
R13	causes_or_contributes_to Arg1:T50 Arg2:T76	
T77	DONE 2413 2417	DONE
